IT1318687B1 - Multi-layer controlled-release tablet comprises an active layer and at least one barrier layer, useful for the treatment of e.g. Parkinson's disease - Google Patents

Multi-layer controlled-release tablet comprises an active layer and at least one barrier layer, useful for the treatment of e.g. Parkinson's disease

Info

Publication number
IT1318687B1
IT1318687B1 IT2000MI001963A ITMI20001963A IT1318687B1 IT 1318687 B1 IT1318687 B1 IT 1318687B1 IT 2000MI001963 A IT2000MI001963 A IT 2000MI001963A IT MI20001963 A ITMI20001963 A IT MI20001963A IT 1318687 B1 IT1318687 B1 IT 1318687B1
Authority
IT
Italy
Prior art keywords
layer
release tablet
parkinson
tablet comprises
disease
Prior art date
Application number
IT2000MI001963A
Other languages
Italian (it)
Inventor
Lauretta Maggi
Ubaldo Conte
Pascal Grenier
Guy Vergnaul
Original Assignee
Jagotec Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jagotec Ag filed Critical Jagotec Ag
Publication of ITMI20001963A0 publication Critical patent/ITMI20001963A0/en
Priority to IT2000MI001963A priority Critical patent/IT1318687B1/en
Priority to ARP010101750A priority patent/AR030557A1/en
Priority to AT01921605T priority patent/ATE401867T1/en
Priority to IL15218401A priority patent/IL152184A0/en
Priority to PL365837A priority patent/PL202689B1/en
Priority to ES01921605T priority patent/ES2307608T3/en
Priority to KR1020097017509A priority patent/KR101158968B1/en
Priority to ES06075502.2T priority patent/ES2580043T3/en
Priority to MXPA02010151A priority patent/MXPA02010151A/en
Priority to PT01921605T priority patent/PT1272167E/en
Priority to KR1020087011476A priority patent/KR20080047630A/en
Priority to AU48576/01A priority patent/AU779623B2/en
Priority to CA2405508A priority patent/CA2405508C/en
Priority to PCT/GB2001/001726 priority patent/WO2001078688A1/en
Priority to KR1020077013182A priority patent/KR20070065922A/en
Priority to DK01921605T priority patent/DK1272167T3/en
Priority to HU0300530A priority patent/HU228269B1/en
Priority to SI200130871T priority patent/SI1272167T1/en
Priority to US10/257,709 priority patent/US20030180359A1/en
Priority to EP01921605A priority patent/EP1272167B1/en
Priority to CNB018091164A priority patent/CN1198598C/en
Priority to DE60134964T priority patent/DE60134964D1/en
Priority to EP06075502.2A priority patent/EP1681051B1/en
Priority to NZ521902A priority patent/NZ521902A/en
Priority to BRPI0110038A priority patent/BRPI0110038C1/en
Priority to EP10176790A priority patent/EP2343060A1/en
Priority to KR1020027013768A priority patent/KR100823392B1/en
Priority to JP2001575989A priority patent/JP5073907B2/en
Priority to CZ20023415A priority patent/CZ303943B6/en
Priority to EP16192165.5A priority patent/EP3175848A1/en
Publication of ITMI20001963A1 publication Critical patent/ITMI20001963A1/en
Priority to IL152184A priority patent/IL152184A/en
Priority to NO20024919A priority patent/NO333572B1/en
Priority to HK03104356A priority patent/HK1053602A1/en
Application granted granted Critical
Publication of IT1318687B1 publication Critical patent/IT1318687B1/en
Priority to AU2005201805A priority patent/AU2005201805B2/en
Priority to US11/717,502 priority patent/US7927624B2/en
Priority to JP2008199847A priority patent/JP5420207B2/en
Priority to US12/478,946 priority patent/US8303986B2/en
Priority to AU2009230759A priority patent/AU2009230759A1/en
Priority to US13/022,281 priority patent/US8460706B2/en

Links

Abstract

A multi-layer controlled-release tablet comprises: (A) an active layer containing (a) an active substance; (b) hydrophilic polymeric substance which swell and/or gel and/or erode upon contact with aqueous liquids; (c) lipophilic substance; and (d) adjuvant substance; and (B) at least one barrier layer containing at least one of (b), (c) and (d). A weight ratio of (b) to (c) in (A) is 10:1 - 0.5:1. An Independent claim is included for the preparation of the tablet involving compression of the powder or granular mixture and working between 1000 - 5000 kg/cm2.
IT2000MI001963A 2000-04-14 2000-09-07 Multi-layer controlled-release tablet comprises an active layer and at least one barrier layer, useful for the treatment of e.g. Parkinson's disease IT1318687B1 (en)

Priority Applications (39)

Application Number Priority Date Filing Date Title
IT2000MI001963A IT1318687B1 (en) 2000-09-07 2000-09-07 Multi-layer controlled-release tablet comprises an active layer and at least one barrier layer, useful for the treatment of e.g. Parkinson's disease
ARP010101750A AR030557A1 (en) 2000-04-14 2001-04-11 A TABLET IN MULTI-MAP OF CONTROLLED RELEASE AND TREATMENT METHOD
MXPA02010151A MXPA02010151A (en) 2000-04-14 2001-04-12 Hydrophilic lipophilic polymeric matrix dosage formulation.
DE60134964T DE60134964D1 (en) 2000-04-14 2001-04-12 Ropinirole-containing dosage form with a hydrophilic / lipophilic matrix
PL365837A PL202689B1 (en) 2000-04-14 2001-04-12 Hydrophilic/lipophilic polymeric matrix dosage formulation
ES01921605T ES2307608T3 (en) 2000-04-14 2001-04-12 DOSAGE FORMULATION CONTAINING ROPINIROL IN A HYDROPHYL / LIPOFILA POLYMERIC MATRIX.
KR1020097017509A KR101158968B1 (en) 2000-04-14 2001-04-12 Hydrophilic/lipophilic polymeric matrix dosage formulation
ES06075502.2T ES2580043T3 (en) 2000-04-14 2001-04-12 Multilayer controlled release tablet comprising an active layer and one or more barrier layers
CNB018091164A CN1198598C (en) 2000-04-14 2001-04-12 Hydrophilic/lipophilic polymeric matrix dosage for mulation
PT01921605T PT1272167E (en) 2000-04-14 2001-04-12 Ropinirole-containing hydrophilic/liphilic polymeric matrix dosage formulation
KR1020087011476A KR20080047630A (en) 2000-04-14 2001-04-12 Hydrophilic/lipophilic polymeric matrix dosage formulation
AU48576/01A AU779623B2 (en) 2000-04-14 2001-04-12 Hydrophilic/lipophilic polymeric matrix dosage formulation
CA2405508A CA2405508C (en) 2000-04-14 2001-04-12 Hydrophilic/lipophilic polymeric matrix dosage formulation
PCT/GB2001/001726 WO2001078688A1 (en) 2000-04-14 2001-04-12 Hydrophilic/lipophilic polymeric matrix dosage formulation
KR1020077013182A KR20070065922A (en) 2000-04-14 2001-04-12 Hydrophilic/lipophilic polymeric matrix dosage formulation
DK01921605T DK1272167T3 (en) 2000-04-14 2001-04-12 Ropinirole-containing hydrophilic / lipophilic polymer matrix dosing formulation
HU0300530A HU228269B1 (en) 2000-04-14 2001-04-12 Hydrophilic/lipophilic polymeric matrix dosage formulation
IL15218401A IL152184A0 (en) 2000-04-14 2001-04-12 Hydrophilic/lipophilic polymeric matrix dosage formulation
US10/257,709 US20030180359A1 (en) 2000-04-14 2001-04-12 Hydrophilic/ lipophilic polymeric matrix dosage formulation
EP06075502.2A EP1681051B1 (en) 2000-04-14 2001-04-12 Multi-layer controlled-release tablet comprising an active layer and one or more barrier layers
AT01921605T ATE401867T1 (en) 2000-04-14 2001-04-12 DOSAGE FORM CONTAINING ROPINIROL WITH A HYDROPHILIC/LIPOPHILIC MATRIX
SI200130871T SI1272167T1 (en) 2000-04-14 2001-04-12 Ropinirole-containing hydrophilic/liphilic polymeric matrix dosage formulation
EP01921605A EP1272167B1 (en) 2000-04-14 2001-04-12 Ropinirole-containing hydrophilic/liphilic polymeric matrix dosage formulation
NZ521902A NZ521902A (en) 2000-04-14 2001-04-12 Hydrophilic/lipophilic polymeric matrix dosage formulation
BRPI0110038A BRPI0110038C1 (en) 2000-04-14 2001-04-12 multilayer controlled release tablet containing ropinirole, and use of ropinirole
EP10176790A EP2343060A1 (en) 2000-04-14 2001-04-12 Multi-layer controlled-release tablet comprising an active layer and one or more barrier layers
KR1020027013768A KR100823392B1 (en) 2000-04-14 2001-04-12 Hydrophilic/lipophilic polymeric matrix dosage formulation
JP2001575989A JP5073907B2 (en) 2000-04-14 2001-04-12 Hydrophilic / lipophilic polymeric matrix dosage formulation
CZ20023415A CZ303943B6 (en) 2000-04-14 2001-04-12 Multi-layer tablet with controlled release of active substance
EP16192165.5A EP3175848A1 (en) 2000-04-14 2001-04-12 Multi-layer controlled-release tablet comprising an active layer and one or more barrier layers
IL152184A IL152184A (en) 2000-04-14 2002-10-08 Multi-layer hydrophilic/lipophilic release tablet
NO20024919A NO333572B1 (en) 2000-04-14 2002-10-11 Ropinirole-containing hydrophilic / lipophilic polymer matrix dosage formulation
HK03104356A HK1053602A1 (en) 2000-04-14 2003-06-17 Ropinirole-containing hydrophilic/liphilic polymeric matrix dosage formulation
AU2005201805A AU2005201805B2 (en) 2000-04-14 2005-04-29 Hydrophilic / lipophilic polymeric matrix dosage formulation
US11/717,502 US7927624B2 (en) 2000-04-14 2007-03-12 Hydrophilic/lipophilic polymeric matrix dosage formulation
JP2008199847A JP5420207B2 (en) 2000-04-14 2008-08-01 Hydrophilic / lipophilic polymeric matrix dosage formulation
US12/478,946 US8303986B2 (en) 2000-04-14 2009-06-05 Hydrophilic/lipophilic polymeric matrix dosage formulation
AU2009230759A AU2009230759A1 (en) 2000-04-14 2009-10-26 Hydrophilic / lipophilic polymeric matrix dosage formulation
US13/022,281 US8460706B2 (en) 2000-04-14 2011-02-07 Hydrophilic/lipophilic polymeric matrix dosage formulation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2000MI001963A IT1318687B1 (en) 2000-09-07 2000-09-07 Multi-layer controlled-release tablet comprises an active layer and at least one barrier layer, useful for the treatment of e.g. Parkinson's disease

Publications (3)

Publication Number Publication Date
ITMI20001963A0 ITMI20001963A0 (en) 2000-09-07
ITMI20001963A1 ITMI20001963A1 (en) 2002-03-07
IT1318687B1 true IT1318687B1 (en) 2003-08-27

Family

ID=11445764

Family Applications (1)

Application Number Title Priority Date Filing Date
IT2000MI001963A IT1318687B1 (en) 2000-04-14 2000-09-07 Multi-layer controlled-release tablet comprises an active layer and at least one barrier layer, useful for the treatment of e.g. Parkinson's disease

Country Status (1)

Country Link
IT (1) IT1318687B1 (en)

Also Published As

Publication number Publication date
ITMI20001963A1 (en) 2002-03-07
ITMI20001963A0 (en) 2000-09-07

Similar Documents

Publication Publication Date Title
AU719170B2 (en) Pharmaceutical compressed tablet characterized by a high increase in volume by contact with biological fluids
MXPA99001958A (en) Tablet with controlled release of alfuzosine chlorydrate.
CA2213996A1 (en) Oral pharmaceutical dosage forms comprising a proton pump inhibitor and an antacid agent or alginate
EP2127642A3 (en) Microemulsions as solid dosage forms for oral administration
CA2417686A1 (en) Manufacture of oral dosage forms delivering both immediate release and sustained release drugs
WO2002045684A3 (en) Rapidly dispersing pharmaceutical composition comprising effervescent agents
WO2004010998A8 (en) Sustained-release tablet comprising reboxetine
CA2342390A1 (en) Sustained release ranolazine formulations
CA2316277A1 (en) Tablet for instant and prolonged release of one or more active substances
CA2402222A1 (en) Sustained release ranolazine formulations
HUP0300530A2 (en) Hydrophilic/lipophilic polymeric matrix dosage formulation
CA2281473A1 (en) Dosage form exhibiting rapid disperse properties, methods of use and process for the manufacture of same
WO2001089479A3 (en) Sustained release pharmaceutical compositions for parenteral administration of hydrophilic compounds
EP1469834A4 (en) Multi-stage oral drug controlled-release system
WO1997045091A3 (en) Sustained release oxycodone formulations with no fed/fast effect
DE69006365T2 (en) UNCOATED PHARMACEUTICAL REACTION TABLET.
EP1131050B8 (en) Galenic formulations fast disintegrating in the mouth and method for preparing same
CA2391439A1 (en) Brittle-coating, soft core dosage form
KR920005809B1 (en) Dispensing devices powered by lyotropic liquid crystals
WO2004075875A8 (en) Dosage form having a saccharide matrix
EP1238662A3 (en) Method for manufacturing drug granules, the drug granules and pharmaceutical preparation containing the drug granules
IT1318470B1 (en) Multi-layer controlled-release tablet comprises an active layer and at least one barrier layer, useful for the treatment of e.g. Parkinson's disease
CA2353693A1 (en) Pharmaceutical composition containing citalopram
IT1318687B1 (en) Multi-layer controlled-release tablet comprises an active layer and at least one barrier layer, useful for the treatment of e.g. Parkinson's disease
BG106342A (en) Low-dose tablets and preparation method